AVPT

Over the past six months, AvePoint's stock (AVPT) has experienced consistent earnings beats and raised guidance, including 26% total revenue growth and 35% SaaS growth in Q1 2026, and a renewed $150 million share buyback program. Barclays initiated coverage with an "Outperform" rating, citing AI-driven growth, and the company has launched AI-related products like "Kinetic Classification" and AvePoint Opus. Analysts generally rate AVPT as a "Moderate Buy" with an average price target suggesting upside, driven by improving fundamentals and demand for AI governance. However, there has been consistent net insider selling totaling approximately $5.3 million over the past 12 months, with no insider purchases. As of October 6, 2026, AVPT closed at $14.59, having lost 4.3% over the past 12 months, fluctuating within a 52-week range of $8.84 to $15.48.